A Case for Cancer Registry Automation

Holly J. Kulhawick, CTR, Supervisor, Cancer Registry, Renown Health
Casefinding is an ongoing struggle for most hospital registries that translates into headaches for their associated Central Registries.

Incidence of testicular germ cell tumors among US men by census region

Armen Ghazarian, MPH, Cancer Research Training Award Fellow, National Cancer Institute
The incidence of testicular cancer, the most commonly occurring cancer among young men in the United States, has long been higher among white men than men of racial/ethnic groups.

Preventable Colon Cancer Deaths Cost the Economy $6.4 Billion

Almost 20 percent of the people in low-income communities who die of colon cancer could have been saved with early screening. And those premature deaths take a toll on communities that can least bear it.

Contribute to NAACCReview!

The NAACCReview has been live for 6 months now and has been averaging a post every two weeks or so. Our small Editorial Board is looking for a few more members to allow us to increase this frequency.

Temporal Trends in and Factors Associated With Contralateral Prophylactic Mastectomy Among US Men With Breast Cancer

Rebecca Cassady, RHIA, CTR, Director, Desert Sierra Cancer Surveillance Program (NAACCR Committee Member)
This article regarding the increase of contralateral prophylactic mastectomies (CPM) in male breast cancer patients is significant as it may change the clinical practice for male breast cancer patients.

Melanoma Risk and Survival among Organ Transplant Recipients

Amy Kahn, MS, Research Scientist, New York State Cancer Registry (NAACCR Committee Member)
Central Cancer Registries from throughout the U.S. have been collaborating with researchers at the National Cancer Institute’s Intramural Research Program

Ovarian Cancer Is Less Deadly Than Previously Thought

One in three women diagnosed with ovarian cancer will live for 10 years or more, according to a new study published in the Journal of Obstetrics and Gynecology — good news, considering ovarian cancer has long been considered highly fatal.

Healthcare law helps sickest Americans — depending on their state

Every year, thousands of people like Blanca Guerra call the National Cancer Information Center, desperate to find some kind of health insurance.

Breast Cancer Screening, Incidence, and Mortality Across US Counties

“As is the case with screening in general, the balance of benefits and harms is likely to be most favorable when screening is directed to those at high risk, provided neither too frequently nor too rarely, and sometimes followed by watchful waiting instead of immediate active treatment”

Meeting the Healthy People 2020 Objectives to Reduce Cancer Mortality

In the near future, cancer is predicted to become the leading cause of death in the United States. It’s already the leading cause of premature deaths.  Every year, we report the rate of cancer deaths is going down while the number of cancer deaths increases. And that is unlikely to change in coming years, as the proportion of older people – those at greatest risk of dying from cancer – increases.

Copyright © 2018 NAACCR, Inc. All Rights Reserved | naaccr-swoosh-only See NAACCR Partners and Sponsors